查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1386510

数位糖尿病管理市场报告：2030 年趋势、预测与竞争分析

Digital Diabetes Management Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

数位糖尿病管理趋势与预测

预计到 2030 年，全球数位糖尿病管理市场将达到 310 亿美元，2024 年至 2030 年年复合成长率为 10.8%。该市场的主要驱动因素是糖尿病盛行率的增加、技术进步以及越来越多地采用云端基础的企业糖尿病管理解决方案。全球数位糖尿病管理市场未来性，在医院、家庭环境和诊断中心市场都有商机。

数位糖尿病管理市场洞察

Lucintel 预测，由于越来越多地采用用于糖尿病管理的智慧胰岛素帮浦和用于自我给药胰岛素的胰岛素贴片，穿戴式装置在预测期内将继续成为较大的细分市场。

在这个市场中，由于越来越多地采用远端患者监护数位技术以及医院内先进的数位糖尿病管理工具的现成可用，预计医院仍将是最大的细分市场。我是。

由于对连网糖尿病管理设备的需求增加、糖尿病管理和肥胖应用程式的快速采用以及该地区自我糖尿病管理意识的不断增强，预计北美地区在预测期内将出现最高的增长。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2.哪个细分市场将以更快的速度成长？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
  • Q.11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

目录

第1章执行摘要

第2章全球数位糖尿病管理市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第3章2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球数位糖尿病管理市场趋势（2018-2023）与预测（2024-2030）
  • 全球数位糖尿病管理市场（按产品）
    • 智慧型血糖仪
    • 连续血糖测量系统
    • 智慧胰岛素笔针
    • 智慧胰岛素泵
    • 应用程式
  • 按类型分類的全球数位糖尿病管理市场
    • 穿戴式装置
    • 手持装置
  • 全球数位糖尿病管理市场（按最终用途）
    • 医院
    • 主页设定
    • 诊断中心

第4章2018-2030年分地区市场趋势及预测分析

  • 全球数位糖尿病管理市场（按地区）
  • 北美数位糖尿病管理市场
  • 欧洲数位糖尿病管理市场
  • 亚太数位糖尿病管理市场
  • 其他区域数位糖尿病管理市场

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 全球数位糖尿病管理市场成长机会（按产品）
    • 全球数位糖尿病管理市场成长机会（按类型）
    • 全球数位糖尿病管理市场的最终用途成长机会
    • 按地区分類的全球数位糖尿病管理市场成长机会
  • 全球数位糖尿病管理市场的新兴趋势
  • 战略分析
    • 新产品开发
    • 全球数位糖尿病管理市场的能力扩张
    • 全球数位糖尿病管理市场的合併、收购与合资企业
    • 认证和许可

第7章主要企业概况

  • Abbott Laboratories
  • Medtronic
  • F. Hoffmann-La Roche
  • Bayer
  • Lifescan
  • Dexcom
  • Sanofi
  • Insulet Corporation
  • Ascensia Diabetes Care Holdings
  • B Braun Melsungen
简介目录

Digital Diabetes Management Trends and Forecast

The future of the global digital diabetes management market looks promising with opportunities in the hospital, home setting, and diagnostic center markets. The global digital diabetes management market is expected to reach an estimated $31.0 billion by 2030 with a CAGR of 10.8% from 2024 to 2030. The major drivers for this market are increasing prevalence of diabetes, technological advancements, and growing adoption of cloud-based enterprise solutions for diabetes management.

A more than 150-page report is developed to help in your business decisions.

Digital Diabetes Management by Segment

The study includes a forecast for the global digital diabetes management by product, type, end use, and region

Digital Diabetes Management Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Smart Glucose Meter
  • Continuous Blood Glucose Monitoring System
  • Smart Insulin Pens
  • Smart Insulin Pumps
  • Apps

Digital Diabetes Management Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Wearable Devices
  • Handheld Devices

Digital Diabetes Management Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Home settings
  • Diagnostic Centers

Digital Diabetes Management Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Digital Diabetes Management Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies digital diabetes management companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the digital diabetes management companies profiled in this report include-

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies digital diabetes management companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the digital diabetes management companies profiled in this report include-

  • Abbott Laboratories
  • Medtronic
  • F. Hoffmann-La Roche
  • Bayer
  • Lifescan
  • Dexcom
  • Sanofi
  • Insulet Corporation
  • Ascensia Diabetes Care Holdings
  • B Braun Melsungen

Digital Diabetes Management Market Insights

Lucintel forecasts that wearable devices will remain the larger segment over the forecast period due to growing adoption of smart insulin pumps and insulin patches for self-insulin delivery for the management of diabetes.

Within this market, hospitals will remain the largest segment due to increasing adoption of digital technologies for remote patient monitoring and easy availability of advanced digital diabetes management tools in hospitals.

North America is expected to witness highest growth over the forecast period due to the increasing demand of connected diabetes management devices, surging adoption of diabetes management and obesity apps, and growing awareness on self-diabetes management in the region.

Features of the Global Digital Diabetes Management Market

Market Size Estimates: Digital diabetes management market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Digital diabetes management market size by product, type, end use, and region in terms of value ($B).

Regional Analysis: Digital diabetes management market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, types, end uses, and regions for the digital diabetes management market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the digital diabetes management market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the digital diabetes management market size?

Answer: The global digital diabetes management market is expected to reach an estimated $31.0 billion by 2030.

Q.2 What is the growth forecast for digital diabetes management market?

Answer: The global digital diabetes management market is expected to grow with a CAGR of 10.8% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the digital diabetes management market?

Answer: The major drivers for this market are increasing prevalence of diabetes, technological advancements, and growing adoption of cloud-based enterprise solutions for diabetes management.

Q4. What are the major segments for digital diabetes management market?

Answer: The future of the digital diabetes management market looks promising with opportunities in the hospital, home setting, and diagnostic center markets.

Q5. Who are the key digital diabetes management market companies?

Answer: Some of the key digital diabetes management companies are as follows:

  • Abbott Laboratories
  • Medtronic
  • F. Hoffmann-La Roche
  • Bayer
  • Lifescan
  • Dexcom
  • Sanofi
  • Insulet Corporation
  • Ascensia Diabetes Care Holdings
  • B Braun Melsungen

Q6. Which digital diabetes management market segment will be the largest in future?

Answer: Lucintel forecasts that wearable devices will remain the larger segment over the forecast period due to growing adoption of smart insulin pumps and insulin patches for self-insulin delivery for the management of diabetes.

Q7. In digital diabetes management market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to the increasing demand of connected diabetes management devices, surging adoption of diabetes management and obesity apps, and growing awareness on self-diabetes management in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the digital diabetes management market by product (smart glucose meter, continuous blood glucose monitoring system, smart insulin pens, smart insulin pumps, and apps ), type (wearable devices and handheld devices), end use (hospitals, home settings, and diagnostic centers), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Digital Diabetes Management Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Digital Diabetes Management Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Digital Diabetes Management Market by Product
    • 3.3.1: Smart Glucose Meter
    • 3.3.2: Continuous Blood Glucose Monitoring System
    • 3.3.3: Smart Insulin Pens
    • 3.3.4: Smart Insulin Pumps
    • 3.3.5: Apps
  • 3.4: Global Digital Diabetes Management Market by Type
    • 3.4.1: Wearable Devices
    • 3.4.2: Handheld Devices
  • 3.5: Global Digital Diabetes Management Market by End Use
    • 3.5.1: Hospitals
    • 3.5.2: Home settings
    • 3.5.3: Diagnostic Centers

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Digital Diabetes Management Market by Region
  • 4.2: North American Digital Diabetes Management Market
    • 4.2.2: North American Digital Diabetes Management Market by End Use: Hospitals, Home settings, and Diagnostic Centers
  • 4.3: European Digital Diabetes Management Market
    • 4.3.1: European Digital Diabetes Management Market by Type: Wearable Devices and Handheld Devices
    • 4.3.2: European Digital Diabetes Management Market by End Use: Hospitals, Home settings, and Diagnostic Centers
  • 4.4: APAC Digital Diabetes Management Market
    • 4.4.1: APAC Digital Diabetes Management Market by Type: Wearable Devices and Handheld Devices
    • 4.4.2: APAC Digital Diabetes Management Market by End Use: Hospitals, Home settings, and Diagnostic Centers
  • 4.5: ROW Digital Diabetes Management Market
    • 4.5.1: ROW Digital Diabetes Management Market by Type: Wearable Devices and Handheld Devices
    • 4.5.2: ROW Digital Diabetes Management Market by End Use: Hospitals, Home settings, and Diagnostic Centers

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Digital Diabetes Management Market by Product
    • 6.1.2: Growth Opportunities for the Global Digital Diabetes Management Market by Type
    • 6.1.3: Growth Opportunities for the Global Digital Diabetes Management Market by End Use
    • 6.1.4: Growth Opportunities for the Global Digital Diabetes Management Market by Region
  • 6.2: Emerging Trends in the Global Digital Diabetes Management Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Digital Diabetes Management Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Digital Diabetes Management Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Abbott Laboratories
  • 7.2: Medtronic
  • 7.3: F. Hoffmann-La Roche
  • 7.4: Bayer
  • 7.5: Lifescan
  • 7.6: Dexcom
  • 7.7: Sanofi
  • 7.8: Insulet Corporation
  • 7.9: Ascensia Diabetes Care Holdings
  • 7.10: B Braun Melsungen